INSIGHT

Discussion Paper: Biologic medicines and biosimilars in the Australian landscape - The challenges and the opportunities

By Ric Morgan
Healthcare

In brief

Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars.

As part of this engagement, we highlight a number of key issues for discussion and comment.

>> Download a PDF copy of the Discussion Paper.